Abstract:Diagram of potential mechanisms by which Notoginsenoside R1 inhibits VEGF‐A‐induced neovascularization Atherosclerosis represents the major cause of mortality worldwide and triggers higher risk of acute cardiovascular events. Pericytes‐endothelial cells (ECs) communication is orchestrated by ligand‐receptor interaction generating a microenvironment which results in intraplaque neovascularization, that is closely associated with atherosclerotic plaque instability. Notoginsenoside R1 (R1) exhibits anti‐atherosclerotic bioactivity, but its effect on angiogenesis in atherosclerotic plaque remains elusive. The aim of our study is to explore the therapeutic effect of R1 on vulnerable plaque and investigate its potential mechanism against intraplaque neovascularization. The impacts of R1 on plaque stability and intraplaque neovascularization were assessed in ApoE−/− mice induced by high‐fat diet. Pericytes‐ECs direct or non‐direct contact co‐cultured with VEGF‐A stimulation were used as the in vitro angiogenesis models. Overexpressing Ang1 in pericytes was performed to investigate the underlying mechanism. In vivo experiments, R1 treatment reversed atherosclerotic plaque vulnerability and decreased the presence of neovessels in ApoE−/− mice. Additionally, R1 reduced the expression of Ang1 in pericytes. In vitro experiments demonstrated that R1 suppressed pro‐angiogenic behavior of ECs induced by pericytes cultured with VEGF‐A. Mechanistic studies revealed that the anti‐angiogenic effect of R1 was dependent on the inhibition of Ang1 and Tie2 expression, as the effects were partially reversed after Ang1 overexpressing in pericytes. Our study demonstrated that R1 treatment inhibited intraplaque neovascularization by governing pericyte‐EC association via suppressing Ang1‐Tie2/PI3K‐AKT paracrine signaling pathway. R1 represents a novel therapeutic strategy for atherosclerotic vulnerable plaques in clinical application.

An arabinogalactan from flowers of Panax notoginseng inhibits angiogenesis by BMP2/Smad/Id1 signaling.

Synthesis of Branched Arabinogalactans Up to a 140-Mer from Panax Notoginseng and Their Anti-Pancreatic-cancer Activity

Notoginsenoside R1 activates the Ang2/Tie2 pathway to promote angiogenesis.

Notoginsenoside R1 Activates the Ang2/Tie2 Pathway to Promote Angiogenesis

RN1, a Novel Galectin-3 Inhibitor, Inhibits Pancreatic Cancer Cell Growth in Vitro and in Vivo Via Blocking Galectin-3 Associated Signaling Pathways

RN0D, a galactoglucan from Panax notoginseng flower induces cancer cell death via PINK1/Parkin mitophagy

In Vitro Evaluation of Panax Notoginseng Rg1 Released from Collagen/chitosan-Gelatin Microsphere Scaffolds for Angiogenesis

Notoginsenoside Ft1 Promotes Angiogenesis Via HIF-1α Mediated VEGF Secretion and the Regulation of PI3K/AKT and Raf/MEK/ERK Signaling Pathways.

An Antitumor Arabinan from Glehnia Littoralis Activates Immunity and Inhibits Angiogenesis.

Raddeanin A, a Triterpenoid Saponin Isolated from Anemone Raddeana, Suppresses the Angiogenesis and Growth of Human Colorectal Tumor by Inhibiting VEGFR2 Signaling.

Ginsenoside-Rb1-Mediated Anti-angiogenesis Via Regulating PEDF and Mir-33A Through the Activation of PPAR-γ Pathway

Notoginsenoside R1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosis

The Angiosuppressive Effects of 20(R)- Ginsenoside Rg3

Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice.

Notoginsenoside R1 Inhibits Oxidized Low-Density Lipoprotein Induced Inflammatory Cytokines Production in Human Endothelial EA.hy926 Cells.

Anti-inflammatory, Anti-Angiogenetic and Antiviral Activities of Dammarane-Type Triterpenoid Saponins from the Roots of Panax Notoginseng.

Anti-angiogenesis and Anti-Tumor Effects of AdNT4-anginex

Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.

Proanthocyanidins, Isolated from Choerospondias Axillaris Fruit Peels, Exhibit Potent Antioxidant Activities in Vitro and a Novel Anti-angiogenic Property in Vitro and in Vivo

Inhibition of tumor-induced angiogenesis and its mechanism by ardipusilloside I purified from Ardisia pusilla

Identification of Bioactive Anti-Angiogenic Components Targeting Tumor Endothelial Cells in Shenmai Injection Using Multidimensional Pharmacokinetics